Retatrutide vs Semaglutide
Overview
Retatrutide and Semaglutide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Retatrutide and Semaglutide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Retatrutide | Semaglutide | |
|---|---|---|
| Category | Weight Management & Metabolic | Weight Management & Metabolic |
| Regulatory status (US) | Research use only | FDA approved |
| Typical dosage | Clinical trials | 0.25-2.4 mg |
| Frequency | weekly | weekly |
| Reported benefits | Enhanced weight loss beyond dual agonists, metabolic improvement | Significant weight loss, improved blood sugar control, reduced cardiovascular risk, appetite suppression |
| Reported side effects | Clinical trial phase | Nausea, vomiting, diarrhea, constipation, potential pancreatitis risk |
Key differences
Primary use. Retatrutide is categorised under Weight Management & Metabolic, while Semaglutide falls under Weight Management & Metabolic. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Retatrutide: not FDA-approved; treated as a research compound. Semaglutide: FDA-approved.
Dosing. Retatrutide is typically dosed at Clinical trials (weekly). Semaglutide is typically dosed at 0.25-2.4 mg (weekly).
Can you stack them?
Some protocols combine peptides, but stacking Retatrutide and Semaglutide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Retatrutide and Semaglutide?
- Retatrutide and Semaglutide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status. Retatrutide is not FDA-approved; generally classified as a research compound, whereas Semaglutide is FDA-approved for one or more indications.
- What is Retatrutide used for?
- Investigational triple agonist (GIP/GLP-1/glucagon). TRIUMPH-1 Phase 3 (May 2026): 28.3% body weight loss at 80 weeks. FDA submission anticipated Q3–Q4 2026.
- What is Semaglutide used for?
- Weight loss, blood sugar control.
- Can you take Retatrutide and Semaglutide together?
- Some users combine peptides within a single protocol, but stacking Retatrutide and Semaglutide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Retatrutide or Semaglutide FDA-approved?
- Retatrutide is not FDA-approved; generally classified as a research compound. Semaglutide is FDA-approved for one or more indications.
Read the full articles
- Retatrutide — full monograph: mechanism, research, dosing & references
- Semaglutide — full monograph: mechanism, research, dosing & references